For example, the candidate drug target CCND1 is located between the two driver genes in the pathways hsa05200: pathways in cancer, hsa05220: chronic myeloid leukemia, hsa05214: glioma, and hsa05218: melanoma. This evidence concerns the gene CCND1 and chronic myelogenous leukemia, BCR-ABL1 positive.